YSB (FRA:B1S) NonCurrent Deferred Liabilities: €0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:B1S YSB Inc FRA:B1S
74 GF Score
Price €0.36
GF Value €0.74
! 5 Warning Signs
View Full Analysis

What is YSB NonCurrent Deferred Liabilities?

YSB FRA:B1S +3.49% 74 NonCurrent Deferred Liabilities is €0 Mil as of Jun. 2026. GuruFocus rates FRA:B1S with a GF Score™ of 74/100 and a GF Value™ of €0.74. The stock has 5 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

YSB's non-current deferred liabilities for the quarter that ended in Jun. 2026 was €0 Mil.

YSB NonCurrent Deferred Liabilities Related Terms

YSB NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for YSB's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

YSB NonCurrent Deferred Liabilities Chart

YSB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

YSB Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:B1S
74GF Score
YSB Inc FRA:B1S
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of €0 Mil mean?
YSB (FRA:B1S) has a NonCurrent Deferred Liabilities of €0 Mil as of Jun. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on YSB and its competitors.
Is YSB's NonCurrent Deferred Liabilities too high?
YSB's current NonCurrent Deferred Liabilities is €0 Mil. Overall, YSB has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does YSB's NonCurrent Deferred Liabilities compare to competitors?
YSB's NonCurrent Deferred Liabilities of €0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Healthcare Providers & Services company?
A good NonCurrent Deferred Liabilities depends on the Healthcare Providers & Services industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on YSB and its competitors. YSB's current NonCurrent Deferred Liabilities is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is YSB stock overvalued right now?
YSB (FRA:B1S) has a current NonCurrent Deferred Liabilities of €0 Mil. The stock's GF Value™ is €0.74, compared to a current price of €0.36 — trading 51.9% below its estimated fair value. The current NonCurrent Deferred Liabilities is €0 Mil. YSB's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For YSB (FRA:B1S), the current NonCurrent Deferred Liabilities is €0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is YSB (FRA:B1S) Overvalued in 2026?

Based on GuruFocus' analysis, YSB stock appears to be undervalued. The current stock price of €0.36 is trading 51.9% below its estimated GF Value™ of €0.74.

Key valuation signals for FRA:B1S:

  • NonCurrent Deferred Liabilities: €0 Mil
  • GF Value™: €0.74 vs. price of €0.36 (51.9% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the FRA:B1S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

YSB Business Description

Other Exchanges 09885:Hong Kong
Address No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN, 510310
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The group is engaged in the wholesale and retail of pharmaceutical and healthcare products through offline channels, retail shops, and its online platform. It also operates an online marketplace that enables pharmaceutical distributors and vendors to sell pharmaceutical and healthcare products through the Group's platform. In addition, the Group provides SaaS solutions to downstream pharmacies and primary healthcare institutions to streamline inventory and patient management, and offers system technologies and operational support services through smart healthcare systems, integrated point-of-care testing and monitoring devices, digital management systems, and smart AI doctor-aid systems.
74GF Score

Get the complete analysis for FRA:B1S

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.36
Price
€0.74
GF Value